Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core

Dr. Gaspard Gerschenfeld, a medical expert in thrombolytics, joins the conversation to discuss the implications of tenecteplase and alteplase in treating patients with large ischemic cores. He highlights a comparative study showing tenecteplase leads to better outcomes and lower mortality compared to alteplase at three months. The use of MRI versus CT scans in stroke assessment is also explored, emphasizing the importance of accurate imaging in urgent care. The dialogue stresses the need for further research to enhance stroke treatment efficacy.